Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024
Diogo Almeida, Diana Mandslay, Peter G. M. Mol, Bruno Sepodes, Carla Torre
Springer Nature ·
2025-08-26
· DOI 10.1007/s40259-025-00737-x
The publisher did not provide an abstract — full text is available via the link below.
Diogo Almeida, Diana Mandslay, Peter G. M. Mol, Bruno Sepodes, Carla Torre. Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024. // BioDrugs. – 2025. – DOI: 10.1007/s40259-025-00737-x. – URL: https://doi.org/10.1007/s40259-025-00737-x
Diogo Almeida, Diana Mandslay, Peter G. M. Mol, Bruno Sepodes, & Carla Torre (2025). Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024. BioDrugs. https://doi.org/10.1007/s40259-025-00737-x
Diogo Almeida, et al. “Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024.” BioDrugs, 2025. doi:10.1007/s40259-025-00737-x.
@article{Almeida2025,
title = {Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024},
author = {Almeida, Diogo and Mandslay, Diana and Mol, Peter G. M. and Sepodes, Bruno and Torre, Carla},
journal = {BioDrugs},
year = {2025},
doi = {10.1007/s40259-025-00737-x},
url = {https://doi.org/10.1007/s40259-025-00737-x}
}